Shlh - Electra Therapeutics announces $84 million Series B financing and unveils its novel SIRP targeted therapies for immunological diseases and cancer

Shlh Recommendations for

Haemophagocytic lymphohistiocytosis (HLH) following allogeneic haematopoietic stem cell transplantation (HSCT)—time to reappraise with modern diagnostic and treatment strategies?

Shlh Recommendations for

Shlh Electra Therapeutics

Electra Therapeutics Announces $84 Million Series B Financing and Unveils Its Novel SIRP‑Targeted Therapies for Immunological Diseases and Cancer

Shlh Haemophagocytic lymphohistiocytosis

Frontiers

Shlh Secondary haemophagocytic

Shlh Secondary Hemophagocytic

Shlh Electra Therapeutics

Recommendations for the management of hemophagocytic lymphohistiocytosis in adults

Shlh ELA026

Shlh Macrophage activation

Shlh Macrophage activation

Frontiers

The exact cut-off for such a decision needs to be defined.

  • Clinical data were independently reviewed by 2 researchers.

  • Since pulmonary infection was easily confused with interstitial lung disease, identification of bacterial, fungal, or tuberculosis infection was a careful and comprehensive decision based on the essential microbiological findings in sputum or blood, clinical manifestations, and radiographic and laboratory abnormalities.

  • Close coordination with haematology colleagues enables prompt diagnosis and treatment.




2022 21stcenturyderm.com